Author

Alfredo Cagnotto

Unknown affiliation - Cited by 4,945

Biography

Alfredo Cagnotto  is affiliated to Department of Molecular Biochemistry and Pharmacology. He is a recipient of many awards and grants for his valuable contributions and discoveries in major area of subject research. His international experience includes various programs, contributions and participation in different countries for diverse fields of study.  His research interests reflect in his wide range of publications in various national and international journals.  
Title
Cited by
Year
Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model
F Re, I Cambianica, C Zona, S Sesana, M Gregori, R Rigolio, B La Ferla, ...Nanomedicine: Nanotechnology, Biology and Medicine 7 (5), 551-559, 2011201
191
2011
Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect Aβ aggregation features and cross the blood–brain-barrier: Implications for therapy of …
L Bana, S Minniti, E Salvati, S Sesana, V Zambelli, A Cagnotto, A Orlando, ...Nanomedicine: Nanotechnology, Biology and Medicine 10 (7), 1583-1590, 2014201
139
2014
Functionalization with ApoE-derived peptides enhances the interaction with brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide
F Re, I Cambianica, S Sesana, E Salvati, A Cagnotto, M Salmona, ...Journal of biotechnology 156 (4), 341-346, 2011201
113
2011
Misplaced NMDA receptors in epileptogenesis contribute to excitotoxicity
A Frasca, M Aalbers, F Frigerio, F Fiordaliso, M Salio, M Gobbi, ...Neurobiology of disease 43 (2), 507-515, 2011201
103
2011
Clusterin binds to Aβ1–42 oligomers with high affinity and interferes with peptide aggregation by inhibiting primary and secondary nucleation
M Beeg, M Stravalaci, M Romeo, AD Carrá, A Cagnotto, A Rossi, ...Journal of Biological Chemistry 291 (13), 6958-6966, 2016201
100
2016
Mono and Dually Decorated Nanoliposomes for Brain Targeting, In Vitro and In Vivo Studies
E Markoutsa, K Papadia, AD Giannou, M Spella, A Cagnotto, M Salmona, ...Pharmaceutical research 31, 1275-1289, 2014201
71
2014
The peculiar role of the A2V mutation in amyloid-β (Aβ) 1–42 molecular assembly
M Messa, L Colombo, E del Favero, L Cantù, T Stoilova, A Cagnotto, ...Journal of Biological Chemistry 289 (35), 24143-24152, 2014201
66
2014
Specific recognition of biologically active amyloid-β oligomers by a new surface plasmon resonance-based immunoassay and an in vivo assay in Caenorhabditis elegans
M Stravalaci, A Bastone, M Beeg, A Cagnotto, L Colombo, G Di Fede, ...Journal of Biological Chemistry 287 (33), 27796-27805, 2012201
64
2012
The hunt for brain Aβ oligomers by peripherally circulating multi-functional nanoparticles: Potential therapeutic approach for Alzheimer disease
S Mancini, S Minniti, M Gregori, G Sancini, A Cagnotto, PO Couraud, ...Nanomedicine: Nanotechnology, Biology and Medicine 12 (1), 43-52, 2016201
62
2016
Functionalization with TAT-peptide enhances blood-brain barrier crossing in vitro of nanoliposomes carrying a curcumin-derivative to bind amyloid-β peptide
G Sancini, M Gregori, E Salvati, I Cambianica, F Re, F Ornaghi, M Canovi, ...JOURNAL OF NANOMEDICINE & NANOTECHNOLOGY 4 (3), 1-8, 2013201
50
2013
The molecular assembly of amyloid Aβ controls its neurotoxicity and binding to cellular proteins
C Manzoni, L Colombo, P Bigini, V Diana, A Cagnotto, M Messa, M Lupi, ...PloS one 6 (9), e209, 2011201
49
2011
Targeting Dopamine D3 and Serotonin 5-HT1A and 5-HT2A Receptors for Developing Effective Antipsychotics: Synthesis, Biological Characterization, and …
M Brindisi, S Butini, S Franceschini, S Brogi, F Trotta, S Ros, A Cagnotto, ...Journal of medicinal chemistry 57 (22), 9578-9597, 2014201
49
2014
Good gene, bad gene: new APP variant may be both
G Di Fede, M Catania, M Morbin, G Giaccone, ML Moro, R Ghidoni, ...Progress in neurobiology 99 (3), 281-292, 2012201
44
2012
Structure–activity relationships and molecular modeling studies of novel arylpiperazinylalkyl 2-benzoxazolones and 2-benzothiazolones as 5-HT7 and 5-HT1A receptor ligands
L Salerno, V Pittalà, MN Modica, MA Siracusa, S Intagliata, A Cagnotto, ...European journal of medicinal chemistry 85, 716-726, 2014201
39
2014
Synthesis and molecular modeling of 1H-pyrrolopyrimidine-2, 4-dione derivatives as ligands for the α1-adrenoceptors
V Pittalà, MA Siracusa, MN Modica, L Salerno, A Pedretti, G Vistoli, ...Bioorganic & medicinal chemistry 19 (17), 5260-5276, 2011201
34
2011
Selenoprotein N is an endoplasmic reticulum calcium sensor that links luminal calcium levels to a redox activity
A Chernorudskiy, E Varone, SF Colombo, S Fumagalli, A Cagnotto, ...Proceedings of the National Academy of Sciences 117 (35), 21288-21298, 2020202
34
2020
Investigation of Functionalized Poly(N,N‐dimethylacrylamide)‐block‐polystyrene Nanoparticles As Novel Drug Delivery System to Overcome the Blood–Brain …
M Gregori, D Bertani, E Cazzaniga, A Orlando, M Mauri, A Bianchi, F Re, ...Macromolecular Bioscience 15 (12), 1687-1697, 2015201
26
2015
Synthesis and binding properties of new long-chain 4-substituted piperazine derivatives as 5-HT1A and 5-HT7 receptor ligands
MN Modica, S Intagliata, V Pittalà, L Salerno, MA Siracusa, A Cagnotto, ...Bioorganic & Medicinal Chemistry Letters 25 (7), 1427-1430, 2015201
26
2015
Tackling amyloidogenesis in Alzheimer’s disease with A2V variants of Amyloid-β
G Di Fede, M Catania, E Maderna, M Morbin, F Moda, L Colombo, ...Scientific reports 6 (1), 20949, 2016201
25
2016
The cell-permeable Aβ1-6A2VTAT (D) peptide reverts synaptopathy induced by Aβ1-42wt
S Cimini, A Sclip, S Mancini, L Colombo, M Messa, A Cagnotto, G Di Fede, ...Neurobiology of Disease 89, 101-111, 2016201
23
2016